CATimelineAuthorisation object

General timespan (max nr days)

30

ATMP/GMO trials (max nr days)

60

Timespan counted from

Confirmation of formal completeness

Additional Information

The sponsor is granted a single opportunity to resubmit amendments upon request of the Ministry (Regulation on Clinical Trials of Medicinal and Biological Products 2014).

This project (ECRIN Integrating Activity/ECRIN-IA) has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 284395
Feedback